Surgical Business Grows: Alcon’s Surgical business continues to gain from the company’s diverse portfolio and incremental innovation. ALC’s flagship lenses, Vivity and PanOptix, continue to lead the ...

According to a team of researchers at the National Institutes of Health, their findings in animals suggest a surgery-free treatment for cataracts. Researchers at the National Institutes of Health (NIH ...

Alcon Inc. is a medical company which is specialized in eye care products. The company develops, manufactures, distributes, and sells technologies and devices for cataract, retinal, refractive ...

Axitinib SR is under clinical development by Alcon and currently in Phase II for Wet (Neovascular / Exudative) Macular Degeneration. According to GlobalData, Phase II drugs for Wet (Neovascular / ...

Cataract remains a major cause of blindness across the world, and corneal conditions can significantly affect vision. In the past full thickness corneal transplants remained the only procedure of ...

and has given talks for Alcon. Patients after cataract surgery at the Project Vision Center in Sanrao.

Novartis’ ophthalmology division Alcon has announced plans to build a digital platform to streamline, simplify and improve cataract surgery for surgeons and patients. Alcon will use its SMART ...